Search

23 Feb 2024: Site Search. ‘Inconsistent’ shielding guidance increases fears for vulnerable lupus patients during the pandemic. ... fatigue, pain, cognitive impairment and others, have received very limited support, treatment or understanding previously.”.

24 Nov 2022: and principle investigator on several other industry and academic vasculitis and lupus trials. ... clinical science. His clinical expertise includes systemic lupus erythematosus and complement deficiency states.

2 Nov 2021: The majority of patients were from the UK (96%) and had inflammatory arthritis (32%) or lupus (32%). ... There was concern, too, that telemedicine increased the potential for inequalities in treatment.

23 Feb 2024: Rituximab as Maintenance Treatment for Systemic Lupus Erythematosus: A Multicenter Observational Study of 147 Patients. ... Randomised controlled trial of prolonged treatment in the remission phase of ANCA-associated vasculitis.

Rituximab as Maintenance Treatment for Systemic Lupus Erythematosus: A Multicenter Observational Study of 147 Patients. ... Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS).

Search. Home. Fellow partners with AstraZeneca to advance the treatment of lupus. ... possibilities for treating patients with systemic lupus erythematosus (also known as SLE or lupus).

2022: Fellow Prof. Rahul Roychoudhuri signs a partnership with AstraZeneca to advance the treatment of lupus.

21 Jul 2023: This antibody, for treatment of rheumatoid arthritis, proved a blockbuster drug with total sales of more than $10 billion by the end of 2009. ... Other antibodies followed, including BENLYSTA, which promises to be the first new drug treatment for

19 Feb 2024: p pThere was concern, too, that telemedicine increased the potential for inequalities in treatment. ... u/u/p pemI feel that she [/emrheumatologistem] doesn’t care about me and so I no longer care about my lupus treatment and medication either.

19 Feb 2024: u/u/p pemI feel that she [/emrheumatologistem] doesn’t care about me and so I no longer care about my lupus treatment and medication either. ... of Cambridge to study the experiences of patients with lupus and related diseases.